
In a randomized controlled trial with forty opioid users, the study investigated the impact of brief cognitive-behavioral therapy (CBT) on general health. The intervention group, undergoing four CBT sessions alongside methadone maintenance therapy, exhibited significant improvements in anxiety and insomnia compared to the control group. However, brief CBT did not significantly impact depression, somatic symptoms, or social dysfunction. The findings suggest the efficacy of brief CBT in addressing specific psychiatric health aspects in opioid users.
Like
Save
Share